X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3776) 3776
Publication (546) 546
Book Chapter (121) 121
Conference Proceeding (35) 35
Book Review (34) 34
Dissertation (9) 9
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
α-synuclein (3460) 3460
alpha-synuclein (2373) 2373
humans (1802) 1802
parkinson's disease (1800) 1800
index medicus (1755) 1755
neurosciences (1554) 1554
parkinsons-disease (1202) 1202
animals (1131) 1131
alpha-synuclein - metabolism (1105) 1105
parkinson’s disease (784) 784
biochemistry & molecular biology (750) 750
lewy bodies (726) 726
male (648) 648
alzheimers-disease (645) 645
neurodegeneration (617) 617
alpha-synuclein - genetics (566) 566
mice (558) 558
clinical neurology (551) 551
parkinson disease - metabolism (507) 507
aggregation (502) 502
α‐synuclein (488) 488
female (485) 485
neurodegenerative diseases (476) 476
pathology (472) 472
oxidative stress (467) 467
mutation (425) 425
nervous system diseases (418) 418
nervous system (415) 415
aged (414) 414
neurology (405) 405
proteins (394) 394
parkinson disease - pathology (385) 385
dementia (380) 380
synuclein (369) 369
multiple system atrophy (364) 364
article (352) 352
brain (350) 350
synucleins (349) 349
dopamine (345) 345
alpha-synuclein - chemistry (335) 335
neurons - metabolism (331) 331
parkinson disease - genetics (329) 329
middle aged (326) 326
brain - metabolism (320) 320
cell biology (319) 319
neurons (317) 317
in-vitro (308) 308
rats (306) 306
protein (284) 284
brain - pathology (279) 279
alzheimer's disease (270) 270
nerve tissue proteins - metabolism (258) 258
immunohistochemistry (257) 257
tau (257) 257
aged, 80 and over (256) 256
substantia-nigra (250) 250
disease models, animal (247) 247
autophagy (238) 238
parkinson disease (234) 234
phosphorylation (232) 232
lewy body (226) 226
biophysics (220) 220
movement disorders (219) 219
neurons - pathology (214) 214
mice, inbred c57bl (211) 211
pathogenesis (208) 208
expression (203) 203
mice, transgenic (182) 182
apoptosis (180) 180
dementia with lewy bodies (177) 177
protein aggregation (173) 173
analysis (171) 171
amyloid (170) 170
cell line, tumor (170) 170
dopamine - metabolism (170) 170
nerve tissue proteins - genetics (170) 170
animal diseases (167) 167
lewy body disease (167) 167
biomedicine (165) 165
lewy bodies - pathology (165) 165
disease (163) 163
oligomers (161) 161
parkin (161) 161
toxicity (161) 161
neurodegenerative disorders (160) 160
pharmacology & pharmacy (156) 156
lewy bodies - metabolism (154) 154
cells, cultured (153) 153
transgenic mice (153) 153
neurotoxicity (152) 152
mental disorders (150) 150
mouse model (148) 148
parkinson disease - physiopathology (148) 148
dopaminergic-neurons (145) 145
lewy body disease - pathology (145) 145
mitochondria (144) 144
parkinsons disease (142) 142
protein binding (142) 142
cell-death (141) 141
medicine & public health (140) 140
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3813) 3813
Japanese (29) 29
Korean (10) 10
German (7) 7
French (5) 5
Chinese (4) 4
Spanish (3) 3
Polish (2) 2
Dutch (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 10/2017, Volume 37, Issue 40, pp. 9617 - 9631
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 12/2019, Volume 132, p. 104582
There are no approved drug therapies that can prevent or slow the progression of Parkinson's disease (PD). Accumulation and aggregation of α-synuclein protein... 
α-Synuclein | Parkinson's | Propagation | Antibody | Immunotherapy | Spreading
Journal Article
03/2011
α-Synuclein is an abundant nerve terminal protein and a primary component of the Lewy body pathology seen in Parkinson’s disease. While the precise biological... 
Rab3a | α-Synuclein | Parkinson's disease | 0317
Dissertation
BBA - Proteins and Proteomics, ISSN 1570-9639, 10/2019, Volume 1867, Issue 10, pp. 890 - 908
α-Synuclein (α-Syn) has been extensively studied for its structural and biophysical properties owing to its pathophysiological role in Parkinson’s disease... 
Aggregation | α-Synuclein | Amyloid | Parkinson’s disease
Journal Article
Experimental Neurology, ISSN 0014-4886, 09/2016, Volume 283, pp. 213 - 223
Synucleinopathy is characterized by abnormal accumulation of misfolded α-synuclein (α-Syn)-positive cytoplasmic inclusions and by neurodegeneration and... 
α-Synuclein | receptor | Synucleinopathy | Hippocampus | Adenosine A
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 05/2013, Volume 125, Issue 5, pp. 753 - 769
We report a British family with young-onset Parkinson's disease (PD) and a G51D SNCA mutation that segregates with the disease. Family history was consistent... 
Multiple system atrophy | α-Synuclein | Parkinson's disease | SNCA | Atrophy | Ubiquitin | Family | Genetic aspects | Dopa
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 04/2015, Volume 112, Issue 15, pp. E1926 - E1935
Journal Article
Neuropathology and Applied Neurobiology, ISSN 0305-1846, 02/2016, Volume 42, Issue 1, pp. 77 - 94
Journal Article
Journal of Neuroscience Methods, ISSN 0165-0270, 01/2019, Volume 311, pp. 89 - 94
Protein aggregation in neurons is a prominent pathological mark of neurodegeneration. In Parkinson’s disease (PD), inclusions of the α-Synuclein (α-Syn)... 
α-Synuclein | CNS | Neurodegeneration | Drosophila | Parkinson’s disease
Journal Article
Neurobiology of disease, ISSN 0969-9961, 8/2018, Volume 116, pp. 53 - 59
Plasma total and nervous system derived exosomal (NDE) α-synuclein have been determined as potential biomarkers of Parkinson’s disease (PD). To explore the... 
Plasma | α-Synuclein | Risk | Parkinson’s | Prodromal
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 07/2019, Volume 115, p. 108843
Many neurodegenerative diseases are characterized by progressive loss of neurons and abnormal protein accumulation, including amyloid (A)β and tau in... 
α-Synuclein | Monoclonal antibody | Immunotherapy | Parkinson’s disease
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 11/2019, Volume 519, Issue 4, pp. 740 - 746
Journal Article
Analytica Chimica Acta, ISSN 0003-2670, 12/2019, Volume 1089, pp. 32 - 39
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 01/2017, Volume 115, Issue 2, pp. 409 - 414
In the neurodegenerative disease multiple system atrophy (MSA), α-synuclein misfolds into a self-templating conformation to become a prion. To compare the... 
Proteinopathy | α-Synuclein | Synucleinopathies | Neurodegeneration | Strains | neurodegeneration | Biological Sciences | proteinopathy | strains | synucleinopathies | α-synuclein
Journal Article
Neuroscience Letters, ISSN 0304-3940, 10/2019, Volume 711, p. 134437
Parkinson’s disease (PD) is characterised pathologically by degeneration of the dopaminergic (DA) neurones of the substantia nigra pars compacta (SNpc) and the... 
Trichloroethylene | α-Synuclein | TaClo | Neurodegeneration | Parkinson’s disease
Journal Article
Biological Psychiatry, ISSN 0006-3223, 05/2019, Volume 85, Issue 9, pp. 769 - 781
Death-associated protein kinase 1 (DAPK1) is a widely distributed serine/threonine kinase that is critical for cell death in multiple neurological disorders,... 
α-Synuclein | miRNA | MPTP | DAPK1 | Peptide | Parkinson’s disease
Journal Article
Brain Research, ISSN 0006-8993, 07/2019, Volume 1715, pp. 203 - 212
The dopaminergic neurodegeneration in the substantia nigra (SN ) and striatum of the midbrain is the important pathological feature of Parkinson's disease... 
α-Synuclein | Apelin-13 | Autophagy | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridin | Parkinson’s disease | Endoplasmic reticulum stress
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.